Medtronic PLC (MDT)

Return on total capital

Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Apr 26, 2024 Jan 31, 2024 Jan 26, 2024 Oct 31, 2023 Oct 27, 2023 Jul 31, 2023 Jul 28, 2023 Apr 30, 2023 Apr 28, 2023 Jan 31, 2023 Jan 27, 2023 Oct 31, 2022 Oct 28, 2022 Jul 31, 2022 Jul 29, 2022 Apr 30, 2022
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 6,717,000 6,051,000 5,834,000 6,093,000 5,787,000 6,225,000 6,093,000 5,787,000 6,041,000 6,278,000 6,401,000 6,597,000 6,202,000 5,978,000 5,607,000 5,277,000 5,717,000 5,951,000 6,421,000 6,939,000
Long-term debt US$ in thousands 21,700,000 21,100,000 20,100,000
Total stockholders’ equity US$ in thousands 49,387,000 48,494,000 47,947,000 50,214,000 50,214,000 51,792,000 51,792,000 51,460,000 51,460,000 51,178,000 51,178,000 51,483,000 51,483,000 51,441,000 51,441,000 51,880,000 51,880,000 52,672,000 52,672,000 52,551,000
Return on total capital 13.60% 12.48% 12.17% 12.13% 11.52% 12.02% 11.76% 11.25% 11.74% 12.27% 12.51% 12.81% 8.47% 11.62% 10.90% 10.17% 7.83% 11.30% 8.82% 13.20%

January 31, 2025 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $6,717,000K ÷ ($—K + $49,387,000K)
= 13.60%

Medtronic PLC's return on total capital has shown fluctuations over the period analyzed. The return on total capital ranged from a low of 7.83% on October 28, 2022, to a high of 13.60% on January 31, 2025. The return on total capital generally trended upwards from the lower values seen in 2022 to the higher values observed in 2025, indicating an improvement in the company's efficiency in generating profits from its capital investments. Overall, the average return on total capital over the period analyzed was 11.35%, reflecting a solid performance in utilizing the company's total capital to generate returns for its investors.